Registration NO:鄂械注准20242404859
This product is used for in vitro qualitative detection of insulin-like growth factor binding protein-1 (IGFBP-1) in vaginal secretions of pregnant women.
【Clinical significance】
IGFBP-1 detection is beneficial for indicating premature rupture of membranes.
【Application scenarios】
Community hospitals, obstetrics.
【Positive judgment value】
When the IGFBP-1 content in the sample is greater than 20ng/mL, it is considered positive.
【Intended Use】
This product is used for in vitro qualitative detection of insulin-like growth factor binding protein-1 (IGFBP-1) in vaginal secretions of pregnant women.
【Product registration certificate number】
鄂械注准20242404859
【Manufacturing Enterprise 】
Wuhan Xurui Biotechnology Co., Ltd
